Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs

@article{Manzoni2002BiosynthesisAB,
  title={Biosynthesis and biotechnological production of statins by filamentous fungi and application of these cholesterol-lowering drugs},
  author={M. Manzoni and M. Rollini},
  journal={Applied Microbiology and Biotechnology},
  year={2002},
  volume={58},
  pages={555-564}
}
Abstract. Hypercholesterolemia is considered an important risk factor in coronary artery disease. Thus the possibility of controlling de novo synthesis of endogenous cholesterol, which is nearly two-thirds of total body cholesterol, represents an effective way of lowering plasma cholesterol levels. Statins, fungal secondary metabolites, selectively inhibit hydroxymethyl glutaryl-coenzyme A (HMG-CoA) reductase, the first enzyme in cholesterol biosynthesis. The mechanism involved in controlling… Expand
Biotechnological production and applications of statins
A review on lovastatin and its production
A REVIEW: LOVASTATIN PRODUCTION AND APPLICATIONS
Heterologous expression of MlcE in Saccharomyces cerevisiae provides resistance to natural and semi-synthetic statins
Single-step fermentative production of the cholesterol-lowering drug pravastatin via reprogramming of Penicillium chrysogenum
Microbial Production and Biomedical Applications of Lovastatin
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 116 REFERENCES
Discovery, biochemistry and biology of lovastatin.
  • A. Alberts
  • Biology, Medicine
  • The American journal of cardiology
  • 1988
Differential metabolism of statins: importance in drug-drug interactions
The structure of the catalytic portion of human HMG-CoA reductase.
Recent advances in the biosynthetic studies of lovastatin.
Monacolins J and L, new inhibitors of cholesterol biosynthesis produced by Monascus ruber.
Aspects of the biosynthesis of non-aromatic fungal polyketides by iterative polyketide synthases
Structural Mechanism for Statin Inhibition of HMG-CoA Reductase
  • Eva S. Istvan, Johann Deisenhofer
  • Chemistry, Medicine
  • Science
  • 2001
Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Production of statins by filamentous fungi
...
1
2
3
4
5
...